Beyond lab-grown meat and biopharmaceuticals lies an entirely new category of biotechnology: materials that are alive, that heal themselves, that grow on demand, and that may one day replace the carbon-intensive foundations of modern civilization.
PROGRAMMING BIOLOGY AS INFRASTRUCTURE
The history of biotechnology can be divided into three eras. In the first, humanity observed what biology did and harvested its products — fermenting grapes, cultivating crops, breeding animals. In the second, humanity learned to redirect biological processes — insulin production in bacteria, gene therapy in human cells, the cellular agriculture that now produces cultivated meat at commercial scale. The third era, which is now beginning, is something qualitatively different: humanity is learning to program biology as a structural material.
Engineered Living Materials — ELMs — are the physical embodiment of this shift. They are composites in which living organisms are not merely present but functional: growing, self-repairing, sensing, and responding to environmental conditions in ways that no inert material can replicate. A concrete wall that heals its own stress fractures. A building facade that captures atmospheric carbon through embedded algae. A fabric that synthesizes vitamins in response to your sweat. These are not science fiction. They are active research programs, several of which have reached proof-of-concept demonstrations in 2025 and 2026.
SELF-HEALING CITIES
Concrete is the most produced material in human history, and also one of its most frustrating: it cracks. Under thermal expansion, seismic stress, and decades of load cycling, concrete inevitably develops microfractures that allow water and chloride ions to penetrate, corroding the reinforcing steel within and initiating structural failure. The conventional response is inspection, patching, and eventual replacement — a process that is labor-intensive, carbon-intensive, and perpetually reactive.
Bio-self-healing concrete inverts this logic entirely. The technology embeds dormant bacterial spores — typically from the Bacillus genus, which can survive the highly alkaline environment of concrete and form protective endospores of extraordinary longevity — directly into the concrete mix. The bacteria remain metabolically inert until cracks form and water infiltrates the matrix. At that point, they activate, metabolize available nutrients through urea hydrolysis, and produce calcium carbonate crystals that precipitate within the crack, sealing it from within.
The mechanism — Microbially Induced Carbonate Precipitation, or MICP — is not new in concept. What has changed dramatically in 2025-26 is the engineering sophistication of its implementation. At the University of Bath, Professor Kevin Paine’s group, operating under the EPSRC RM4L scheme, concluded a landmark real-world trial using a two-component micro-encapsulation system that keeps bacterial spores and nutrients in separate protective beads until crack-induced release. The trial demonstrated that self-healing bacterial concrete can maintain compressive strengths comparable to conventional mixes while retaining bacterial viability over extended storage periods.
Critically, the Bath group worked with psychrotrophic cave bacteria — cold-adapted strains that germinate at 5-20 degrees Celsius, ensuring healing capability in temperate climates rather than only in warm-weather geographies. This addresses a long-standing critique of earlier bioconcrete research, which used bacteria optimized for human body temperature and thus performed poorly in Northern European or high-altitude deployments.
Research published in the journal NextMaterials in January 2026 synthesized the current state of the field, confirming that Bacillus-based bacteria with appropriate encapsulation strategies can reduce water absorption and chloride ion penetration to a degree that meaningfully extends structural service life. Integration of bacterial healing with low-carbon concrete formulations — geopolymers, slag blends, limestone calcined clay cements — is reducing embodied carbon by 20 to 40 percent compared to ordinary Portland cement while adding active self-repair capability.
The economics remain challenging. Bacterial cultures and nutrient additives currently increase production costs by 20 to 30 percent over conventional concrete. But maintenance and replacement costs — absent over the extended service life of healed structures — are not trivial. A bridge that repairs its own microcracks may simply cost less over a 100-year lifespan than one that requires $50 million of resurfacing every two decades.
“Our novel approach into smart materials could transform our infrastructure by embedding self-immunity and resilience so that structures can evolve over their lifespan.” — Prof. Kevin Paine, University of Bath
LIVING FUNGUS, BREATHING BUILDINGS
Bacteria are not the only biological system being recruited as structural architects. In April 2025, researchers published in Cell Reports Physical Science a landmark demonstration of a building material constructed from fungal mycelium — the root-like network of thread-like filaments that constitute the vegetative body of fungi — combined with bacterial cells. The resulting composite, manufactured at low temperatures using entirely biological processes, demonstrated self-repair capability extending over a month following mechanical damage.
Mycelium-based materials have attracted intense research interest for their extraordinary combination of properties: they are lightweight, thermally insulating, vapor-permeable, acoustically absorbing, fire-resistant, and — crucially — biodegradable at end of life. Companies including Ecovative Design and Mogu have already commercialized mycelium composites for packaging and interior wall panels. The 2025 publication moves the frontier significantly: mycelium as a scaffold for biomineralization, where fungal networks guide the deposition of mineral crystals that provide structural strength while the living organisms repair damage.
The researchers acknowledge a key limitation: biomineralized materials do not yet achieve the compressive strength required for load-bearing structural applications. But they and other groups are actively working on mechanical enhancement strategies, and the performance envelope is expanding rapidly. The vision is not a world without concrete but one in which living materials occupy niches where their unique properties — self-repair, carbon sequestration, biodegradability, and biological responsiveness — offer advantages that no inert material can match.
WEARABLE BIO-FACTORIES
The frontier of Engineered Living Materials extends from architecture into apparel, and from architecture’s massive scales to the intimate scale of skin contact. Researchers at several institutions are developing textile systems in which engineered microorganisms are integrated into fabric structures — surviving, metabolizing, and producing biochemicals in response to physiological cues from the wearer.
The concept of wearable biosynthesis addresses a genuine medical problem: many topical treatments require consistent application that patient compliance makes unreliable. Fabrics engineered with probiotic bacteria that respond to changes in skin pH — triggered by sweat composition — could deliver vitamins, anti-inflammatory compounds, or antibiotics directly to the skin surface as needed, with dosing governed by the body’s own signaling. Research groups have demonstrated proof-of-concept with vitamin B12-producing bacteria integrated into textile matrices, with production rates responsive to thermal and chemical stimuli.
The regulatory pathway for such materials is necessarily complex. A fabric that produces pharmaceuticals on the skin is simultaneously a textile, a medical device, and a biological product — a regulatory trichotomy that existing frameworks are not designed to handle. But the technical progress is outpacing regulatory clarity in ways that will force institutional adaptation.
SYNTHETIC BIOLOGY 2.0
The conceptual foundation beneath all these applications is what researchers now describe as Synthetic Biology 2.0 — a transition from ‘using’ biology’s existing capabilities to ‘writing’ new biological functions from genetic first principles. Where first-generation synthetic biology involved swapping genes between organisms or knocking out specific metabolic pathways, the emerging paradigm involves the wholesale design of genetic circuits that give organisms programmable responses to environmental triggers.
CRISPR-based genome editing, expanded genetic codes incorporating non-standard amino acids, and the development of orthogonal biological systems that operate independently of the host organism’s native metabolism have together created a design space of unprecedented richness. The question for Engineered Living Materials is no longer ‘what can biology do?’ but ‘what do we need it to do, and how do we write the instructions?’
This is not a hypothetical future. The biocalcifying bacteria now entering concrete trials have been genetically modified to upregulate urease production — the enzyme that drives calcium carbonate precipitation — making them more efficient in the alkaline concrete environment. The psychrotrophic strains developed at Bath represent organisms specifically selected and potentially engineered for performance in conditions where wild-type bacteria would perish.
INFRASTRUCTURE AT THE BOUNDARY OF LIFE AND MATTER
The implications of Engineered Living Materials for India are particularly resonant. India’s construction sector faces a dual pressure: massive infrastructure demand driven by urbanization and economic growth, and acute vulnerability to the climate impacts — flooding, extreme heat, seismic activity — that degrade conventional materials. Bioconcrete with built-in moisture-responsive healing, biocomposite facades that manage heat through living systems, and structural elements designed for controlled end-of-life biodegradation could address multiple dimensions of this challenge simultaneously.
The science is ahead of the regulatory frameworks, the manufacturing supply chains, and — in most markets — the procurement specifications. But the trajectory is clear. The built environment of 2050 will not consist solely of inert materials waiting passively to be repaired. It will include structures that participate actively in their own maintenance, that sense and respond to their environment, and that return to the biosphere rather than the landfill at their end of life. The cellular architects are already at work.
–Srinivasa Rao Srikantam




